Literature DB >> 23380297

Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function.

Julie Martin1, Sébastien Bergeron, Philippe Pibarot, Marjorie Bastien, Laurent Biertho, Odette Lescelleur, Fernand Bertrand, Serge Simard, Paul Poirier.   

Abstract

BACKGROUND: Obesity is often associated with left ventricular (LV) diastolic dysfunction (DD). Elevated N-terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) is considered a biomarker of LV dysfunction. Weight loss induced by bariatric surgery may improve LV DD, but conflicting results regarding NT-proBNP levels have been reported. Our objective was to determine the impact of bariatric surgery-induced weight loss on NT-proBNP levels and LV DD.
METHODS: Seventy (70) patients were evaluated before and 6 and 12 months following a biliopancreatic diversion with duodenal switch (BPD-DS), and 33 subjects were followed as controls at baseline and 6 and 12 months later. Blood was collected for NT-proBNP measurement, and LV diastolic function was assessed with echocardiography.
RESULTS: Among the 103 severely obese patients, 82% presented some degree of LV DD. Systolic function was preserved in all subjects. Along with significant weight loss, LV DD significantly improved (P < 0.001) in the BPD-DS group, whereas there was no change in the control group. NT-proBNP levels decreased over time in the control group (P = 0.016) and increased in subjects following BPD-DS (baseline vs 6-month vs 12-month follow-up: 51.8 ± 62.8 vs 132.0 ± 112.9 vs 143.3 ± 120.4 pg/mL; P < 0.001). The most significant associations with changes in NT-proBNP levels were improvements in the metabolic profile.
CONCLUSIONS: In severely obese patients, NT-proBNP levels decrease with sustained obesity for 1 year. Despite significant improvements in LV DD following bariatric surgery, NT-proBNP levels increase. These results suggest that monitoring NT-proBNP levels following bariatric surgery may be misleading regarding LV DD and symptoms of dyspnea.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380297     DOI: 10.1016/j.cjca.2012.11.010

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  14 in total

1.  Sleeve gastrectomy in obese Wistar rats improves diastolic function and promotes cardiac recovery independent of weight loss.

Authors:  Hailey Hayes; Jacob Patz; John Corbett; Muhammad Z Afzal; Jennifer Strande; Tammy L Kindel
Journal:  Surg Obes Relat Dis       Date:  2019-03-23       Impact factor: 4.734

2.  Cardiovascular Changes After Gastric Bypass Surgery: Involvement of Increased Secretions of Glucagon-Like Peptide-1 and Brain Natriuretic Peptide.

Authors:  Maria-Pia Gandolfini; Muriel Coupaye; Elodie Bouaziz; Monique Dehoux; David Hajage; Jean-Marc Lacorte; Séverine Ledoux
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

Review 3.  Obesity Surgery and Anesthesiology Risks: a Review of Key Concepts and Related Physiology.

Authors:  Sjaak Pouwels; Marc P Buise; Pawel Twardowski; Pieter S Stepaniak; Monika Proczko
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

4.  The effect of weight loss on the cardiac structure and function after laparoscopic adjustable gastric banding surgery in morbidly obese individuals.

Authors:  Vilma Dzenkeviciūte; Zaneta Petrulioniene; Virginijus Sapoka; Sigita Aidietiene; Lina Abaraviciute
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

5.  Short-Term Changes in Cardiovascular Hemodynamics in Response to Bariatric Surgery and Weight Loss Using the Nexfin® Non-invasive Continuous Monitoring Device: a Pilot Study.

Authors:  Sjaak Pouwels; Bianca Lascaris; Simon W Nienhuijs; Arthur R Bouwman; Marc P Buise
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

6.  Bariatric Surgery-Induced Resolution of Hypertension and Obstructive Sleep Apnea: Impact of Modulation of Body Fat, Ectopic Fat, Autonomic Nervous Activity, Inflammatory and Adipokine Profiles.

Authors:  Audrey Auclair; Laurent Biertho; Simon Marceau; Frédéric-Simon Hould; Simon Biron; Stéfane Lebel; François Julien; Odette Lescelleur; Yves Lacasse; Marie-Eve Piché; Katherine Cianflone; Sebastian Demian Parlee; Kerry Goralski; Julie Martin; Marjorie Bastien; David H St-Pierre; Paul Poirier
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

7.  Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity.

Authors:  Sarah-Maude Caron-Cantin; Julie Martin; Marjorie Bastien; Mercedes Nancy Munkonda; Huiling Lu; Katherine Cianflone; Fady Moustarah; Laurent Biertho; Simon Marceau; Frédéric-Simon Hould; Jean Bussières; Paul Poirier
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

Review 8.  The Effects of Bariatric Surgery on Cardiac Structure and Function: a Systematic Review of Cardiac Imaging Outcomes.

Authors:  Ravi Aggarwal; Leanne Harling; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

9.  Is There a Role for Visceral Adiposity in Inducing Type 2 Diabetes Remission in Severely Obese Patients Following Biliopancreatic Diversion with Duodenal Switch Surgery?

Authors:  Audrey Auclair; Julie Martin; Marjorie Bastien; Nadine Bonneville; Laurent Biertho; Simon Marceau; Frédéric-Simon Hould; Simon Biron; Stéfane Lebel; Odette Lescelleur; Jean-Pierre Després; Paul Poirier
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

Review 10.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.